Veri-T: A Trial of Verdiperstat in Patients With svPPA Due to TDP-43 Pathology
Clinical trial NCT05184569 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05184569
- Sponsor
- Peter Ljubenkov, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2027-01-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.